1. Busulfan, melphalan, and bortezomib compared to melphalan as a high dose regimen for autologous hematopoietic stem cell transplantation in multiple myeloma: long term follow up of a novel high dose regimen. Issue 14 (5th December 2020) Authors: Hagen, Patrick; D'Souza, Anita; Hari, Parameswaran; Davila, Omar; Zhang, Mei-Jie; Vesole, David H.; Smith, Scott E.; Rodriguez, Tulio E.; Stiff, Patrick J. Journal: Leukemia & lymphoma Issue: Volume 61:Issue 14(2020) Page Start: 3484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Busulfan, melphalan, and bortezomib compared to melphalan as a high dose regimen for autologous hematopoietic stem cell transplantation in multiple myeloma: long term follow up of a novel high dose regimen. Issue 14 (5th December 2020) Authors: Hagen, Patrick; D'Souza, Anita; Hari, Parameswaran; Davila, Omar; Zhang, Mei-Jie; Vesole, David H.; Smith, Scott E.; Rodriguez, Tulio E.; Stiff, Patrick J. Journal: Leukemia & lymphoma Issue: Volume 61:Issue 14(2020) Page Start: 3484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗